OMI-nously Yours: Is it time to re-think Code STEMI?
Cardiovascular disease remains one of the leading causes of death worldwide, accounting for approximately 32% of deaths globally.¹ Acute myocardial infarction (MI)... Read more.
Vernakalant versus procainamide for rapid cardioversion of patients with acute atrial fibrillation (RAFF4): randomised clinical trial
Methodology Score: 4.5/5 Usefulness Score: 4/5 Stiell IG, et al. BMJ. 2025 Nov 11;391:e085632. doi: 10.1136/bmj-2025-085632. Question and Methods: This is a multi-center,... Read more.
